Atazanavir: A viewpoint

Peter J. Piliero; Robert L. Murphy

doi:10.2165/00003495-200363160-00004

Atazanavir: A viewpoint

Peter J. Piliero^*, Robert L. Murphy

^*Corresponding author for this work

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Number of pages	1
Journal	Drugs
Volume	63
Issue number	16
DOIs	https://doi.org/10.2165/00003495-200363160-00004
State	Published - Jan 1 2003

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.2165/00003495-200363160-00004

Cite this

@article{b6b4f2d4e62a46dea71b5f31db9eba87,

title = "Atazanavir: A viewpoint",

author = "Piliero, {Peter J.} and Murphy, {Robert L.}",

year = "2003",

month = jan,

day = "1",

doi = "10.2165/00003495-200363160-00004",

language = "English (US)",

volume = "63",

journal = "Drugs",

issn = "0012-6667",

publisher = "Adis International Ltd",

number = "16",

}

TY - JOUR

T1 - Atazanavir

T2 - A viewpoint

AU - Piliero, Peter J.

AU - Murphy, Robert L.

PY - 2003/1/1

Y1 - 2003/1/1

UR - http://www.scopus.com/inward/record.url?scp=0043235636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043235636&partnerID=8YFLogxK

U2 - 10.2165/00003495-200363160-00004

DO - 10.2165/00003495-200363160-00004

M3 - Comment/debate

AN - SCOPUS:0043235636

VL - 63

JO - Drugs

JF - Drugs

SN - 0012-6667

IS - 16

ER -

Atazanavir: A viewpoint

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this